Literature DB >> 11470276

Agonist-induced internalization and mitogen-activated protein kinase activation of the human prostaglandin EP4 receptor.

S Desai1, B Ashby.   

Abstract

We examined the pathway of prostaglandin E(2) (PGE(2))-induced internalization of the prostaglandin EP4 receptor in HEK 293 cells. Co-expression of dominant negative beta-arrestin (319-418) or dynamin I (K44A) with the EP4 receptor reduced internalization. The activated receptor co-localized with GFP-arrestin 2 and GFP-arrestin 3, confirming the requirement for beta-arrestins in internalization. Inhibition of clathrin-coated vesicle-mediated internalization resulted in inhibition of sequestration, whereas inhibition of caveola-mediated internalization had no effect. PGE(2) stimulation of the EP4 receptor resulted in rapid mitogen-activated protein (MAP) kinase activation. Examination of an internalization-resistant mutant and co-expression of mutant accessory proteins with EP4 revealed that MAP kinase activation proceeds independently of internalization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470276     DOI: 10.1016/s0014-5793(01)02640-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Role of beta-arrestin 1 in the metastatic progression of colorectal cancer.

Authors:  F Gregory Buchanan; D Lee Gorden; Pranathi Matta; Qiong Shi; Lynn M Matrisian; Raymond N DuBois
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 2.  Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease.

Authors:  Eitan A Friedman; Martin L Ogletree; Elias V Haddad; Olivier Boutaud
Journal:  Thromb Res       Date:  2015-05-28       Impact factor: 3.944

3.  Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4.

Authors:  Chao Xie; Bojian Liang; Ming Xue; Angela S P Lin; Alayna Loiselle; Edward M Schwarz; Robert E Guldberg; Regis J O'Keefe; Xinping Zhang
Journal:  Am J Pathol       Date:  2009-07-23       Impact factor: 4.307

4.  Prostaglandin E2 stimulates the production of amyloid-beta peptides through internalization of the EP4 receptor.

Authors:  Tatsuya Hoshino; Takushi Namba; Masaya Takehara; Tadashi Nakaya; Yukihiko Sugimoto; Wataru Araki; Shuh Narumiya; Toshiharu Suzuki; Tohru Mizushima
Journal:  J Biol Chem       Date:  2009-04-30       Impact factor: 5.157

5.  Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor.

Authors:  Xiaosong Gu; Jiang Xu; Liping Zhu; Timothy Bryson; Xiao-Ping Yang; Edward Peterson; Pamela Harding
Journal:  Circ Heart Fail       Date:  2016-08       Impact factor: 8.790

6.  Identification of a Ser/Thr cluster in the C-terminal domain of the human prostaglandin receptor EP4 that is essential for agonist-induced beta-arrestin1 recruitment but differs from the apparent principal phosphorylation site.

Authors:  Frank Neuschäfer-Rube; Ricardo Hermosilla; Mathias Rehwald; Lars Rönnstrand; Ralf Schülein; Christer Wernstedt; Gerhard Paul Püschel
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

7.  Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction.

Authors:  Jian-Yong Qian; Pamela Harding; Yunhe Liu; Ed Shesely; Xiao-Ping Yang; Margot C LaPointe
Journal:  Hypertension       Date:  2008-01-07       Impact factor: 10.190

8.  Proteomic profiling of the hypothalamus in a mouse model of cancer-induced anorexia-cachexia.

Authors:  R Ihnatko; C Post; A Blomqvist
Journal:  Br J Cancer       Date:  2013-09-03       Impact factor: 7.640

Review 9.  The multiple faces of prostaglandin E2 G-protein coupled receptor signaling during the dendritic cell life cycle.

Authors:  Sandra De Keijzer; Marjolein B M Meddens; Ruurd Torensma; Alessandra Cambi
Journal:  Int J Mol Sci       Date:  2013-03-25       Impact factor: 5.923

Review 10.  E-type prostanoid receptor 4 (EP4) in disease and therapy.

Authors:  Viktoria Konya; Gunther Marsche; Rufina Schuligoi; Akos Heinemann
Journal:  Pharmacol Ther       Date:  2013-03-21       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.